World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
38592
World Ranking
9961
National Ranking
5128

Overview

Michael A. Quinn is affiliated with the International Gynaecological Cancer Society in the United States. Their research primarily spans the field of Medicine, with a particular focus on Surgery, Epidemiology, Genetics, Obstetrics and Gynecology, and Reproductive Medicine.

The scientist's work covers several main topics, including:

  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Cervical Cancer and HPV Research
  • Advances in Oncology and Radiotherapy
  • Knee injuries and reconstruction techniques
  • Shoulder Injury and Treatment
  • Genetic Mapping and Diversity in Plants and Animals

Michael A. Quinn has published frequently in the following venues:

  • International Journal of Gynecological Cancer
  • Frontiers in Plant Science
  • Orthopaedic Journal of Sports Medicine
  • Osteoporosis International
  • The Lancet Oncology

The scientist has collaborated often with several co-authors in their research, including Thomas C. Randall, Linus Chuang, Joseph Ng, Kathleen M. Schmeler, and Benton E. Heyworth.

Among their recent papers are:

  • Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial, 2023, The Lancet Oncology
  • Breeding Schemes: What Are They, How to Formalize Them, and How to Improve Them?, 2022, Frontiers in Plant Science
  • Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer, 2020, Scientific Reports
  • Improving response to progestin treatment of low-grade endometrial cancer, 2020, International Journal of Gynecological Cancer
  • Cost-effectiveness of balloon kyphoplasty and vertebroplasty versus conservative medical management in the USA, 2020, Osteoporosis International

Best Publications

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Carcinoma of the Ovary.

    A. P. M. Heintz;F. Odicino;P. Maisonneuve;M. A. Quinn

  • Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

    W T Creasman;F Odicino;P Maisonneuve;M A Quinn

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.

    Amit M. Oza;Adrian D. Cook;Jacobus Pfisterer;Andrew Embleton

  • Revised FIGO staging for carcinoma of the cervix uteri

    Neerja Bhatla;Jonathan S. Berek;Mauricio Cuello Fredes;Lynette A. Denny

  • Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

    M A Quinn;J L Benedet;F Odicino;P Maisonneuve

  • Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics

    Mike Quinn;Penny Babb;Jennifer Jones;Elizabeth Allen

  • Standard cancer patient population for age standardising survival ratios

    Isabella Corazziari;Mike Quinn;Riccardo Capocaccia

  • Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

    Gordon John Sampson Rustin;Ignace Vergote;Elizabeth Eisenhauer;Eric Pujade-Lauraine

  • 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

    A du Bois;M Quinn;T Thigpen;J Vermorken

  • Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

    Stephanie M. de Boer;Melanie E. Powell;Linda Mileshkin;Dionyssios Katsaros

  • Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons

    M. Quinn;P. Babb

  • Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality.

    R G Blanks;S M Moss;C E McGahan;M J Quinn

  • European Code Against Cancer and scientific justification: third version (2003)

    P. Boyle;P. Autier;H. Bartelink;J. Baselga

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    Stephanie M de Boer;Melanie E Powell;Linda Mileshkin;Dionyssios Katsaros

  • Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001

    M P Coleman;B Rachet;L M Woods;E Mitry

  • Chapter 8: Screening for cervical cancer in developing countries.

    Lynette Denny;Michael Quinn;R. Sankaranarayanan

  • Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)

    Gordon J. S. Rustin;Michael Quinn;Tate Thigpen;Andreas du Bois

Frequent Co-Authors

Gregory E. Rice
Gregory E. Rice University of Queensland
Jock K. Findlay
Jock K. Findlay Hudson Institute of Medical Research
Suzanne M. Garland
Suzanne M. Garland University of Melbourne
Michel P Coleman
Michel P Coleman London School of Hygiene & Tropical Medicine
Sepehr N. Tabrizi
Sepehr N. Tabrizi Royal Women's Hospital
Penelope M. Webb
Penelope M. Webb QIMR Berghofer Medical Research Institute
Michael Friedlander
Michael Friedlander University of New South Wales
Danny Rischin
Danny Rischin Peter MacCallum Cancer Centre
Erik W. Thompson
Erik W. Thompson Queensland University of Technology
Mark S. Baker
Mark S. Baker Macquarie University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can open doors to rewarding careers even if medical school isn’t your chosen route. Many students opt for adn programs (Associate Degree in Nursing), which provide a faster track to becoming a registered nurse. These programs are typically more accessible and allow for quicker entry into the workforce.

For those interested in administrative roles, an online healthcare administration degree can lead to management opportunities in hospitals, clinics, or insurance companies. This flexible option is ideal for working professionals looking to advance or change careers.

If you’re searching for a less traditional path, online medical billing and coding with financial aid programs can prepare you to enter the growing field of healthcare information management. These roles are vital and offer remote work possibilities.

Some prospective nurses are concerned about entrance exams. Fortunately, there are nursing schools that don't require teas or hesi exams, making it easier to begin your nursing journey.

These diverse online pathways offer flexibility, accessibility, and real-world career prospects for those passionate about healthcare.

Best Scientists Citing Michael A. Quinn

Trending Scientists